Keywords: fujisawa, fk838, enters, phase, ii, trials, pharmaceutical

Fujisawa's FK838 Enters Phase II Trials

Article | 19 December 1994

Fujisawa Pharmaceutical has begun Phase II trials of its new antihypertensive diuretic, FK383. The agent, a selective adeonosine (A1) receptor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Fujisawa Pharmaceutical

Go to company listing

Related Drugs

Nystatin

Go to drug listing